Overcoming barriers to deploying AI in drug discovery pipelines, from data silos to regulatory validation at scale.

How AI is transforming patient recruitment, adaptive trial design, and real-world data analysis in clinical research.

How agentic AI reduces administrative burden, streamlines protocol submissions, and automates safety reporting.

AI tools for expediting FDA and EMA submissions, pharmacovigilance, and post-market surveillance activities.

Leveraging genomic data and AI to develop targeted therapies and optimise individual treatment pathways.

Turning real-world data into actionable insights for drug safety, effectiveness, and market access decisions.

Executives share how AI is reshaping R&D culture, talent strategy, and competitive advantage in the pharma industry.

How LLMs are accelerating literature review, patent analysis, clinical documentation, and hypothesis generation.

Improving patient outcomes with AI-powered diagnostics, adherence monitoring, and digital therapeutics platforms.